Residents and fellows at Mayo Clinic in Rochester, Minnesota, are leveraging the Mayo Clinic Platform’s extensive database of deidentified patient records to enhance clinical decision-making and research. Highlighted during the Platform Experience Day, this initiative involves tens of millions of records, providing a significant resource for medical training and innovation.

The Centers for Medicare & Medicaid Services (CMS) released data showing that insurers denied 19% of in-network claims for ACA Marketplace plans in 2024. This significant denial rate highlights the challenges consumers face, as they rarely appeal these decisions. The high denial rate is attributed to various factors, including administrative errors and policy exclusions. Moving…

Oryon Cell Therapies has emerged from stealth with a $21m Series A funding round to advance its autologous neuron replacement therapy for Parkinson’s disease. This funding brings Oryon’s total capital to $42m, enabling further development of its phase 1b/2a trial. The therapy involves unilateral implantation of fully developed A9 neurons, showing promising improvements in motor…

Hospital cyberattacks, such as the ransomware incident at the University of Mississippi Medical Center, pose significant threats to patient safety and healthcare operations. These attacks disrupt critical services, highlighting the vulnerability of healthcare systems to cyber threats. Ricardo Amper discusses the increasing targeting of healthcare institutions by cybercriminals, emphasizing the need for robust cybersecurity measures….

Tallahassee Memorial Healthcare has filed a lawsuit against a patient who has refused to vacate her hospital room five months after discharge. The hospital claims her continued occupancy is diverting resources and preventing the use of the bed for other patients requiring acute care. Despite efforts to coordinate her departure and offer transportation for identification,…

Major pharmaceutical companies are being challenged by the U.S. government over allegations of overcharging low-income patients for medications. This legal action could impact millions who rely on affordable drugs under government programs. The claims suggest these companies violated pricing agreements meant to protect vulnerable populations. The Trump administration is pushing for accountability, which may lead…